Regulation 1993/793 - Evaluation and control of the risks of existing substances

Contents

  1. Legislative text
  2. 31993R0793

1.

Legislative text

Avis juridique important

|

2.

31993R0793

Council Regulation (EEC) No 793/93 of 23 March 1993 on the evaluation and control of the risks of existing substances

Official Journal L 084 , 05/04/1993 P. 0001 - 0075

Finnish special edition: Chapter 15 Volume 12 P. 0093

Swedish special edition: Chapter 15 Volume 12 P. 0093

COUNCIL REGULATION (EEC) No 793/93 of 23 March 1993 on the evaluation and control of the risks of existing substances

THE COUNCIL OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Economic Community, and in particular Article 100a thereof,

Having regard to the proposal from the Commission(1) ,

In cooperation with the European Parliament(2) ,

Having regard to the opinion of the Economic and Social Committee(3) ,

Whereas disparities between the laws, regulations and administrative provisions relating to the risk evaluation of existing substances which are in effect or in preparation in the Member States are liable to hinder trade between Member States and create unequal conditions of competition;

Whereas measures for the approximation of the provisions of the Member States which have as their object the establishment and functioning of the internal market must, in so far as they concern health, safety, environmental and consumer protection, take a high level of protection as a basis;

Whereas, in order to ensure the protection of man, including workers and consumers, and of the environment, it is necessary to carry out at Community level a systematic evaluation of the risks involving existing substances appearing in the Einecs (European Inventory of Existing Commercial Substances)(4) ;

Whereas, in the interests of efficiency and economy, it is necessary to establish a Community policy which will ensure a sharing and coordination of responsibilities between Member States, the Commission and industrialists;

Whereas a Regulation is the appropriate legal instrument as it imposes directly on manufacturers and importers precise requirements to be implemented at the same time and in the same manner throughout the Community;

Whereas, in order to undertake a preliminary risk evaluation of existing substances and to identify priority substances requiring immediate attention, it is necessary to collect certain information and test data on existing substances;

Whereas the requirement to provide such information should not apply to certain substances which, on the basis of their intrinsic properties, involve only risks generally recognized as minimal;

Whereas the information should be submitted by manufacturers and importers to the Commission, which will send copies to all Member States; whereas, however, it should be possible for a Member State to ask manufacturers and importers established in its territory to submit the same information at the same time to its competent authorities;

Whereas, for the purpose of the risk evaluation of certain existing substances, it is necessary, in certain cases, to require manufacturers or importers to submit further data or to carry out further testing on given existing substances;

Whereas it is necessary to draw up, at Community level, lists of priority substances which require special attention; whereas the Commission should submit not later than one year after the entry into force of this Regulation an initial priority list;

Whereas the risk evaluation of substances on the priority lists should be carried out by the Member States; whereas the latter should be designated at Community level on the basis of a distribution of responsibilities taking account of the situation of the Member States; whereas risk evaluation principles should also be established at Community level;

Whereas, in the priority-setting process and risk evaluation of existing substances, it is necessary to take into account, in particular, the lack of data on the effects of the substance, the work already carried out in other international organizations, such as the Organization for Economic Cooperation and Development, and other legislation and/or Community programmes concerning dangerous substances;

Whereas it is necessary to adopt at Community level the results of the risk evaluation and the recommended strategy for limiting risks in respect of substances on the priority lists;

Whereas it is appropriate to reduce to a minimum the number of animals used for experimental purposes in accordance with the provisions of Council Directive 86/609/EEC of 24 November 1986 on the approximation of laws, regulations and administrative provisions of the Member States regarding the protection of animals used for experimental and other scientific purposes(5) ; whereas, wherever possible and in consultation, in particular, with the European Centre for Alternative Testing Methods, the use of animals must be avoided by recourse to validated alternative procedures;

Whereas for tests on chemical substances to be carried out in the context of this Regulation it is necessary to follow the good laboratory practices set out in Council Directive 87/18/EEC of 18 December 1986 on the harmonization of laws, regulations and administrative provisions relating to the application of the principles of good laboratory practice and the verification of their application for tests on chemical substances(6) ;

Whereas the Commission, assisted by a committee made up of representatives of the Member States, should be given the necessary powers to adapt certain Annexes to technical progress and to adopt certain implementing measures in respect of the Regulation;

Whereas the confidential nature of certain information covered by industrial or commercial secrecy should be guaranteed,

HAS ADOPTED THIS REGULATION:

Article 1

Aims and scope

  • 1. 
    This Regulation shall apply to:

(a) the collection, circulation and accessibility of information on existing substances;

(b) the evaluation of the risks of existing substances to man, including workers and consumers, and to the environment, in order to ensure better management of those risks within the framework of Community provisions.

  • 2. 
    The provisions of this Regulation shall apply without prejudice to Community legislation on the protection of workers and consumers.

Article 2

Definitions

For the purpose of this Regulation:

(a) substances means chemical elements and their compounds in the natural state or obtained by any production process, including any additive necessary to preserve the stability of the product and any impurity deriving from the process used, but excluding any solvent which may be separated without affecting the stability of the substance or changing its composition;

(b) preparations means mixtures or solutions composed of two or more substances;

(c) importing means bringing into the customs territory of the Community;

(d) producing means the production of substances which are isolated in a solid, liquid or gaseous form;

(e) existing substances means substances listed in Einecs.

PART 1 SYSTEMATIC DATA REPORTING AND ESTABLISHMENT OF LISTS OF PRIORITY SUBSTANCES

Article 3

Data reporting on high volume production or import of existing substances

Without prejudice to Article 6 (1), any manufacturer who has produced or any importer who has imported an existing substance, as such or in a preparation, in quantities exceeding 1 000 tonnes per year, at least once in the three years preceding the adoption of this Regulation and/or the year following its adoption, must submit to the Commission, in accordance with the procedure laid down in Article 6 (2) and (3), the following information, as specified in Annex III, within 12 months of entry into force of this Regulation in the case of a substance appearing in Annex I and within 24 months in the case of a substance appearing in Einecs but not in Annex I:

(a) the name and the Einecs number of the substance;

(b) the quantity of the substance produced or imported;

(c) the classification of the substance according to Annex I to Council Directive 67/548/EEC of 27 June 1967 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the classification, packaging and labelling of dangerous substances(7) or the provisional classification according to the said Directive, including the class of danger, the danger symbol, the risk phrases and the safety phrases;

(d) information on the reasonably foreseeable uses of the substance;

(e) data on the physico-chemical properties of the substance;

(f) data on pathways and environmental fate;

(g) data on the ecotoxicity of the substance;

(h) data on the acute and subacute toxicity of the substance;

(i) data on carcinogenicity, mutagenicity and/or toxicity for reproduction of the substance;

(j) any other indication relevant to the risk evaluation of the substance.

Manufacturers and importers must make all reasonable efforts to obtain existing data regarding points (e) to (j). However, in the absence of information, manufacturers and importers are not bound to carry out further tests on animals in order to submit such data.

Article 4

Data reporting on lower volume production or import of existing substances

  • 1. 
    Without prejudice to Article 6 (1), any manufacturer who has produced, or any importer who has imported, an existing substance, as such or in a preparation, in quantities exceeding 10 tonnes per year but no greater than 1 000 tonnes per year, at least once in the three years preceding the adoption of this Regulation and/or the year following its adoption, shall submit to the Commission, in accordance with the procedure laid down in Article 6 (2) and (3), the following information, as specified in Annex IV, within a period of 24 months, to start once the Regulation has been in force for three years:

(a) the name of the substance and the Einecs number;

(b) the quantity of the substance produced or imported;

(c) the classification of the substance according to Annex I to Directive 67/548/EEC or the provisional classification according to the said Directive, including the class of danger, the danger symbol, the risk phrases and the safety phrases;

(d) information on the reasonably foreseeable uses of the substance.

  • 2. 
    The Commission, in consultation with the Member States, shall determine the cases in which it is necessary to request the manufacturers and importers of the substances declared in pursuance of paragraph 1 to submit additional information, in the framework of Annex III, on the physico-chemical properties, toxicity, and ecotoxicity of such substances, exposure and any other aspect relevant to the risk evaluation of the substances. However, without prejudice to Article 12 (2), manufacturers and importers are not bound to carry out further tests on animals for that purpose.

The specific information to be submitted and the procedure to be followed for this submission shall be determined in accordance with the procedure laid down in Article 15.

Article 5

Exemptions

The substances listed in Annex II shall be exempt from the provisions of Articles 3 and 4. However, information on the substances listed in Annex II may be requested by a procedure laid down in accordance with the procedure referred to in Article 15.

Article 6

Procedure for data reporting

  • 1. 
    In the case of a substance produced or imported by several manufacturers or importers, the information referred to in Article 3 and Article 4 (2) may be submitted by one manufacturer or importer acting, with their agreement, on behalf of other manufacturers or importers concerned. The latter shall nevertheless submit to the Commission the information specified in points 1.1 to 1.19 of the data set laid down in Annex III and, in doing so, shall make reference to the data set submitted by the manufacturer or importer.
  • 2. 
    In submitting the information referred to in Article 3 and in Article 4 (1), the manufacturers and importers shall use only the special software package on diskette made available free of charge by the Commission.
  • 3. 
    Member States may provide that manufacturers and importers established in their territory shall be required to submit simultaneously to their competent authorities the same information as that forwarded to the Commission pursuant to Articles 3 and 4.
  • 4. 
    On receipt of the data referred to in Articles 3 and 4 respectively, the Commission shall forward copies to all the Member States.

Article 7

Updating of the reported information and obligation to submit certain information spontaneously

  • 1. 
    Manufacturers and importers who have submitted information on a substance in accordance with Articles 3 and 4 shall update the information forwarded to the Commission.

In particular, they shall submit, where appropriate:

(a) new uses of the substance which substantially change the type, form, magnitude or duration of exposure of man or the environment to the substance;

(b) new data obtained on the physico-chemical properties, toxicological or ecotoxicological effects where this is likely to be relevant to the evaluation of the potential risk presented by the substance;

(c) any change in the provisional classification under Directive 67/548/EEC.

They shall also be required to update the information regarding the production and import volumes referred to in Articles 3 and 4 every three years, if there is a change in relation to the volumes specified in Annex III or Annex IV.

  • 2. 
    Any manufacturer or importer of an existing substance who acquires knowledge which supports the conclusion that the substance in question may present a serious risk to man or the environment shall immediately report such information to the Commission and to the Member State in which he is located.
  • 3. 
    Upon receipt of the data referred to in paragraphs 1 and 2, the Commission shall submit copies thereof to all the Member States.

Article 8

Priority lists

  • 1. 
    On the basis of the information submitted by manufacturers and importers in accordance with Articles 3 and 4, and on the basis of the national lists of priority substances, the Commission, in consultation with Member States, shall regularly draw up lists of priority substances or groups of substances (hereinafter referred to as priority lists) requiring immediate attention because of their potential effects on man or the environment. These lists shall be adopted in accordance with the procedure laid down in Article 15 and shall be published by the Commission for the first time in the course of the year following the entry into force of the Regulation.
  • 2. 
    The factors to be taken into account in drawing up the priority lists shall be:
  • - 
    the effects of the substance on man or the environment,
  • - 
    the exposure of man or the environment to the substance,
  • - 
    the lack of data on the effects of the substance on man and the environment,
  • - 
    work already carried out in other international fora,
  • - 
    other Community legislation and/or programmes relating to dangerous substances.

A substance subject to evaluation under other Community legislation should be placed on a priority list only if that evaluation fails to cover risk to the environment or risk to man, including workers and consumers, or if those risks have not been adequately evaluated. An equivalent evaluation carried out under other Community legislation should not be repeated under this Regulation.

Special attention shall be given to substances which may have chronic effects, in particular substances known or suspected to be carcinogenic, toxic to reproduction and/or mutagenic or known or suspected to increase the incidence of these effects.

Article 9

Data to be supplied for substances appearing on the priority lists

  • 1. 
    For the substances included in the priority lists referred to in Article 8 (1), manufacturers and importers who have submitted information on a substance in accordance with Articles 3 and 4 shall, within six months of publication of the list, submit to the rapporteur designated in accordance with Article 10 (1) all relevant available information and corresponding study reports for risk assessment of the substance concerned.
  • 2. 
    In addition to the requirement specified in paragraph 1, and without prejudice to the testing which may be required under Article 10 (2), if any of the particulars listed in Annex VII A to Directive 67/548/EEC are not available for a given priority substance, the manufacturers and importers who have submitted information on a substance in accordance with Articles 3 and 4 shall be obliged to carry out the testing necessary to obtain the missing data and to provide the test results and test reports to the rapporteur within 12 months.
  • 3. 
    By way of derogation from paragraph 2, manufacturers and importers may request of the rapporteur that they be exempted from some or all of the additional testing on the grounds that a given piece of information is either unnecessary for risk assessment or is impossible to obtain; they may also request a longer period where circumstances so require. Full justification must be provided to support such derogation and the rapporteur shall decide whether the request should be accepted. Where derogations are allowed in conformity with this Article, the rapporteur shall immediately inform the Commission of his decision. The Commission shall inform the other Member States. If the decision of the rapporteur is contested by one of the other Member States, a final decision shall be taken in conformity with the committee procedure laid down in Article 15.

PART 2 RISK EVALUATION

Article 10

Risk evaluation of the substances on the priority lists at the level of the Member State designated as rapporteur

  • 1. 
    For each substance on the priority lists a Member State shall be given responsibility for its evaluation in accordance with the procedure laid down in Article 15, whilst ensuring fair burden sharing between Member States.

The Member State shall designate a rapporteur for that substance from among the competent authorities referred to in Article 13.

The rapporteur shall be responsible for evaluating the information submitted by the manufacturer(s) or importer(s) in conformity with the requirements of Articles 3, 4, 7 and 9 and any other available information, and for identifying, after consultation of the producers or importers concerned, whether, for the purpose of the risk evaluation, it is necessary to require the above manufacturers or importers of priority substances to submit further information and/or to carry out further testing.

  • 2. 
    Where the rapporteur considers it necessary to request further information and/or testing, it shall inform the Commission accordingly. The decision to impose on the above importers or manufacturers a request for further information and/or testing and the time limits for responding to that request shall be taken in accordance with the procedure laid down in Article 15.
  • 3. 
    The rapporteur for a given priority substance shall evaluate the risk of that substance to man and the environment.

Where appropriate, it shall suggest a strategy for limiting these risks, including control measures and/or surveillance programmes. Where such control measures include recommendations for restrictions on the marketing or use of the substance in question, the rapporteur shall submit an analysis of the advantages and drawbacks of the substance and of the availability of replacement substances.

The recommended risk evaluation and strategy shall be forwarded to the Commission by the rapporteur.

  • 4. 
    The real or potential risk to man and the environment shall be assessed on the basis of principles adopted, by 4. June 1994, in accordance with the procedure laid down in Article 15. These pinciples shall be regularly reviewed and, where appropriate, revised in accordance with the same procedure.
  • 5. 
    When manufacturers or importers are asked for further information and/or testing, they must also check, in view of the need to limit practical experiments on vertebrates, whether the information needed to evaluate the substance is not available from former manufacturers or importers of the declared substance and cannot be obtained, possibly against payment of costs. Where experiments are essential, it must be checked whether tests on animals cannot be replaced or limited by using other methods.

Necessary laboratory tests must be performed with due respect for the principles of 'good laboratory practice' as laid down in Directive 87/18/EEC and for the provisions of Directive 86/609/EEC.

Article 11

Risk evaluation of the substances on the priority lists at Community level

  • 1. 
    On the basis of the risk evaluation and measures recommended by the rapporteur, the Commission shall submit to the Committee referred to in Article 15 (1) a proposal concerning the results of the risk evaluation of the priority substances and, if necessary, a recommendation for an appropriate strategy for limiting those risks.
  • 2. 
    The results of the risk evaluation of the priority substances, and the recommended strategy shall be adopted at Community level in accordance with the procedure laid down in Article 15, and shall be published by the Commission.
  • 3. 
    On the basis of the risk evaluation and the recommended strategy referred to in paragraph 2, the Commission shall decide, where necessary, to propose Community measures in the framework of Council Directive 76/769/EEC of 27 July 1976 on the approximation of the laws, regulations and administrative provisions of the Member States relating to restrictions on the marketing and use of certain dangerous substances and preparations (8) or in the framework of other relevant existing Community instruments.

Article 12

Obligations relating to the provision of further information and to further testing

  • 1. 
    Any manufacturer or importer of a substance appearing on the priority lists referred to in Article 8 (1) and who has submitted the information under Articles 3 and 4 must, within a given time limit, supply the rapporteur with the data and test results concerning that substance referred to in Article 9 (1) and (2) and those referred to in Article 10 (2).
  • 2. 
    Without prejudice to Article 7 (2), where there are valid reasons for believing that a substance appearing in Einecs may present a serious risk to man or the environment, a decision to ask the manufacturer(s) and importer(s) of the said substance to supply the information which they possess and/or to subject the existing substance to testing and provide a report thereon shall be taken in accordance with the procedure laid down in Article 15.
  • 3. 
    In the case of a substance produced or imported as such or in a preparation by several manufacturers or importers, testing in pursuance of paragraphs 1 and 2 may be performed by one or more manufacturers or importers acting on behalf of other manufacturers or importers concerned. The other manufacturers or importers concerned shall make reference to the tests carried out by that or those manufacturers or importers and shall make a fair and equitable contribution to the cost.

Article 13

Collaboration between the Member States and the Commission

Member States shall designate one or more competent authorities to participate in the implementation of this Regulation in collaboration with the Commission, in particular for the work referred to in Articles 8 and 10. The Member States shall also designate the authority or authorities to which the Commission shall send the copy of the data received.

PART 3 MANAGEMENT, CONFIDENTIALITY, MISCELLANEOUS AND FINAL PROVISIONS

Article 14

Amendment and adaptation of the Annexes

  • 1. 
    The amendments necessary for adapting Annexes I, II, III and IV to technical progress shall be adopted in accordance with the procedure laid down in Article 15.
  • 2. 
    The amendments and adaptations to Annex V shall be adopted by the Commission.

Article 15

Committee

  • 1. 
    The Commission shall be assisted by a Committee composed of the representatives of the Member States and chaired by the representative of the Commission.
  • 2. 
    The representative of the Commission shall submit to the Committee a draft of the measures to be taken. The Committee shall deliver its opinion on the draft within a time limit which the Chairman may lay down according to the urgency of the matter. The opinion shall be delivered by the majority laid down in Article 148 (2) of the Treaty in the case of decision which the Council is required to adopt on a proposal from the Commission. The votes of the representatives of the Member States within the Committee shall be weighted in the manner set out in that Article. The Chairman shall not vote.
  • 3. 
    The Commission shall adopt the measures envisaged if they are in accordance with the opinion of the Committee.

If the measures envisaged are not in accordance with the opinion of the Committee, or if no opinion is delivered, the Commission shall, without delay, submit to the Council a proposal relating to the measures to be taken. The Council shall act by a qualified majority.

  • 4. 
    (a) Except in the cases referred to in subparagraph (b) below, if, on the expiry of a period of two months from the date of referral to the Council, the Council has not acted, the proposed measures shall be adopted by the Commission.

(b) In the case of decisions referred to in Article 11 (2) and Article 14 (1) if, on the expiry of a period of two months from the date of referral to the Council, the Council has not acted, the proposed measures shall be adopted by the Commission, save where the Council has decided against the said measures by a simple majority.

Article 16

Confidentiality of data

  • 1. 
    If he considers that there is a confidentiality problem, the manufacturer or importer may indicate the information provided for in Articles 3, 4, 7 and 12, which he considers to be commercially sensitive and disclosure of which might harm him industrially or commercially, and which he therefore wishes to be kept secret from all persons other than Member States and the Commission. Full justification must be given in such cases.

Industrial and commercial secrecy shall not apply to:

  • - 
    the name of the substance, as given in Einecs,
  • - 
    the name of the manufacturer or importer,
  • - 
    data on physico-chemical properties of the substance and on pathways and environmental fate,
  • - 
    the summary results of the toxicological and ecotoxicological tests, in particular data on carcinogenity, mutagenicity and/or the substance's toxicity for reproduction,
  • - 
    any information relating to the methods and precautions relating to the substance and the emergency measures,
  • - 
    any information which, if withheld, might lead to animal experiments being carried out or repeated needlessly,
  • - 
    analytical methods that make it possible to detect a dangerous substance when discharged into the environment as well as to determine the direct exposure of humans to the substance.

If the manufacturer or importer should himself later disclose previously confidential information, he shall inform the competent authority accordingly.

  • 2. 
    The authority receiving the information shall decide on its own responsibility which information is covered by industrial and commercial secrecy in accordance with paragraph 1.

Information accepted as being confidential by the authority receiving the information shall be treated as being confidential by the other authorities.

Article 17

Not later than one year following adoption of this Regulation, Member States shall establish appropriate legal or administrative measures in order to deal with non-compliance with the provisions of this Regulation.

Article 18

This Regulation shall enter into force on the 60th day following its publication in the Official Journal of the European Communities.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 23 March 1993.

For the Council The President S. AUKEN

  • (1) 
    OJ No C 276, 5. 11. 1990, p. 1.
  • (2) 
    OJ No C 280, 28. 10. 1991, p. 65 and OJ No C 337, 21. 12. 1992.
  • (3) 
    OJ No C 102, 18. 4. 1991, p. 42.
  • (4) 
    OJ No C 146, 15. 6. 1990, p. 1.
  • (5) 
    OJ No L 358, 18. 12. 1986, p. 1.
  • (6) 
    OJ No L 15, 17. 1. 1987, p. 29.
  • (7) 
    OJ 196, 16. 8. 1967, p. 1. Directive as last amended by Commission Directive 91/632/EEC (OJ No L 338, 10. 12. 1991, p. 23).
  • (8) 
    OJ No L 262, 27. 9. 1976, p. 201. Directive as last amended by Directive 91/659/EEC (OJ No L 363, 31. 12. 1991, p. 36).

ANNEX I

LIST OF EXISTING SUBSTANCES PRODUCED OR IMPORTED WITHIN THE COMMUNITY IN QUANTITIES EXCEEDING 1 000 TONNES PER YEAR (*) (*) The petroleum products are grouped into 31 groups identified by a number or a number and a letter (group 1, group 2, group 3A, group 3B, group 3C, group 4A, group 4B, etc.), see pages 35 to 68.

For any one particular group of substances, manufacturers or importers may decide to submit only one set of information, but only in so far as points 2 to 6 inclusive of the information as laid down in Annex III are concerned; this information will then be taken as applying to all substances contained within that particular group.

ANNEX II

LIST OF SUBSTANCES EXEMPT FROM THE PROVISIONS OF ARTICLES 3 AND 4

ANNEX III

INFORMATION REFERRED TO IN ARTICLE 3 1. General information

1.1. Name of substance

1.2. Einecs No

1.3. CAS No

1.4. Synonyms

1.5. Purity

1.6. Impurities

1.7. Molecular formula

1.8. Structural formula

1.9. Type of substance

1.10. Physical state

1.11. Please indicate who is submitting the data set

1.12. Quantity produced or imported, greater than 1 000 tonnes per year

1.13. Indicate if the substance has been produced during the last 12 months

1.14. Indicate if the substance has been imported during the last 12 months

1.15. Classification and labelling

1.16. Use pattern

1.17. Has the complete data set already been submitted by another manufacturer or importer?

1.18. Specify if you are acting on behalf of another concerned manufacturer or importer

1.19. Other remarks: (e. g. options for disposal)

  • 2. 
    Physical-chemical data

2.1. Melting point

2.2. Boiling point

2.3. Density

2.4. Vapour pressure

2.5. Partition coefficient (log10 POW)

2.6. Water solubility

2.7. Flash point

2.8. Auto flammability

2.9. Flammability

2.10. Explosive properties

2.11. Oxidizing properties

2.12. Other data and remarks

  • 3. 
    Environmental fate and pathways

3.1. Stability

3.1.1. Photodegradation

3.1.2. Stability in water

3.1.3. Stability in soil

3.2. Monitoring data (environment)

3.3. Transport and distribution between environmental compartments including estimated environmental concentrations and distribution pathways

3.3.1. Transport

3.3.2. Distribution among environmental compartments

3.4. Biodegradation

3.5. Bioaccumulation

3.6. Other remarks

  • 4. 
    Ecotoxicity

4.1. Toxicity to fish

4.2. Toxicity to daphnia and other aquatic invertebrates

4.3. Toxicity to algae

4.4. Toxicity to bacteria

4.5. Toxicity to terrestrial organisms

4.6. Toxicity to soil dwelling organisms

4.7. Other remarks

  • 5. 
    Toxicity

5.1. Acute toxicity

5.1.1. Acute oral toxicity

5.1.2. Acute inhalation toxicity

5.1.3. Acute dermal toxicity

5.1.4. Acute toxicity (other routes of administration)

5.2. Corrosiveness and irritation

5.2.1. Skin irritation

5.2.2. Eye irritation

5.3. Sensitization

5.4. Repeated dose toxicity

5.5. Genetic toxicity in vitro

5.6. Genetic toxicity in vivo

5.7. Carcinogenicity

5.8. Toxicity to reproduction

5.9. Other relevant information

5.10. Experience with human exposure

  • 6. 
    List of references

ANNEX IV

INFORMATION REFERRED TO IN ARTICLE 4 (1) 1. General information

1.1. Name of substance

1.2. Einecs No

1.3. CAS No

1.4. Synonyms

1.5. Purity

1.6. Impurities

1.7. Molecular formula

1.8. Structural formula

1.9. Type of substance

1.10. Physical state

1.11. Please indicate who is submitting the data set

1.12. Quantity produced or imported exceeding 10 tonnes per year but not greater than 1 000 tonnes

1.13. Indicate if the substance has been produced during the last 12 months

1.14. Indicate if the substance has been imported during the last 12 months

1.15. Classification and labelling

1.16. Use pattern

1.17. Other remarks

ANNEX V

COMMUNITY INFORMATION OFFICES The special software packages are available, on diskette, at the following information offices in the Community

Germany

Bonn

Kommission der Europaeischen Gemeinschaften

Vertretung in der Bundesrepublik Deutschland

Zitelmannstrasse 22

D-5300 Bonn

Telex 88 66 48 EUROP D

Telefax 5 30 09 50

Berlin

Kommission der Europaeischen Gemeinschaften

Vertretung in der Bundesrepublik Deutschland

Aussenstelle Berlin

Kurfuerstendamm 102

D-1000 Berlin 31

Telex 18 40 15 EUROP D

Telefax 8 92 20 59

Munich

Kommission der Europaeischen Gemeinschaften

Vertretung in der Bundesrepublik Deutschland

Vertretung in Muenchen

Erhardtstrasse 27

D-8000 Muenchen 2

Telex 5 21 81 35

Telefax 2 02 10 15

Belgium

Brussels

(a) Commission des Communautés européennes

Bureau en Belgique

(b) Commissie van de Europese Gemeenschappen

Bureau in België

Rue Archimede 73, B-1040 Bruxelles

Archimedesstraat 73, B-1040 Brussel

Telex 26657 COMTNF B

Telefax 2 35 01 66

Denmark

Copenhagen

Kommissionen for De Europaeiske Faellesskaber

Kontor in Danmark

Hoejbrohus

OEstergade 61

Postbox 144

DK-1004 Koebenhavn K 33

Telex 1 64 02 COMEUR DK

Telefax 33 11 12 03/33 14 12 44

Spain

Madrid

Comisión de las Comunidades Europeas

Oficina en España

Calle de Serrano 41

5a planta

E-28001 Madrid

Telex 4 68 18 OIPE E

Telefax 2 76 03 87

Barcelona

Edificio Atlantico

Av. Diagonal, 407 bis, Planta 18

08008 Barcelona

Telefax 415 63 11

France

Paris

Commission des Communautés européennes

Bureau de représentation en France

288, Bld. St. Germain

F-75007 Paris

Telex Paris 611019 COMEUR

Telefax 1 45 56 94 19/7

Marseilles

Commission des Communautés européennes

Bureau á Marseille

CMCI

2, rue Henri-Barbusse

F-13241 Marseille Cedex 01

Telex 40 25 38 EURMA

Telefax 91 90 98 07

Greece

Athens

Epitropi ton Evropaikon Koinotiton

Grafeio stin Ellada

2 Vassilissis Sofias

Case postale 1 10 02

GR-Athina 10674

Telex 21 93 24 ECAT GR

Telefax 7 24 46 20

Ireland

Dublin

Commission of the European Communities

Office in Ireland

39 Molesworth Street

IRL-Dublin 2

Telex 9 38 27 EUCO EI

Telefax 71 26 57

Italy

Roma

Commissione delle Comunità europee

Ufficio in Italia

Via Poli 29

I-00187 Roma

Telex 61 01 84 EUROMA I

Telefax 6 79 16 58

Milan

Commissione delle Comunità europee

Ufficio a Milano

Corso Magenta 59

I-20123 Milano

Telex 31 62 00 EURMIL I

Telefax 4 81 85 43

Luxembourg

Luxembourg

Commission des Communautés européennes

Bureau au Luxembourg

Bâtiment Jean Monnet B/0

Rue Alcide De Gasperi

L-2920 Luxembourg

Telex 34 23/34 46/34 76 COMEUR LU

Telefax 43 01 44 33

Netherlands

The Hague

Commissie van de Europese Gemeenschappen

Bureau in Nederland

Korte Vijverberg 5

NL-2513 AB Den Haag

Telex 3 10 94 EURCO NL

Telefax 364 66 19

Portugal

Lisbon

Comissao das Comunidades Europeias

Gabinete em Portugal

Centro Europeu Jean Monnet

Largo Jean Monnet 1-10o

P-1200 Lisboa

Telex 18810 COMEUR P

Telefax 1 55 43 97

United Kingdom

London

Commission of the European Communities

Office in the United Kingdom

Jean Monnet House

8 Storey's Gate

UK-London SW1P 3AT

Telex 2 32 08 EURUK G

Telefax 7 19 73 19 00/19 20

Belfast

Commission of the European Communities

Office in Northern Ireland

Windsor House

9/15 Bedford Street

UK-Belfast BT2 7EG

Telex 7 41 17 CECBEL G

Telefax 24 82 41

Cardiff

Commission of the European Communities

Office in Wales

4 Cathedral Road

PO Box 15

UK-Cardiff CF1 9SG

Telex 49 77 27 EUROPA G

Telefax 39 54 89

Edinburgh

Commission of the European Communities

Office in Scotland

7 Alva Street

UK-Edinburgh EH2 4PH

Telex 72 74 20 EUEDING

Telefax 2 26 41 05

This summary has been adopted from EUR-Lex.